1947:
1937:
1917:
1897:
1887:
1349:
1339:
1329:
1927:
1907:
1359:
1036:
29:
739:
717:
1817:
1395:
595:
502:
1981:
687:
626:
226:
deals. In the early 2000s, it started investing in Asia, mainly in China due to the opportunities provided. The biotech firms that Vivo invests in tend to already have new treatments in
709:
1991:
1890:
532:
1332:
799:
1996:
2001:
1976:
464:
1388:
428:
1971:
1464:
657:
562:
1950:
1381:
1309:
1862:
1213:
587:
498:
320:
1986:
679:
618:
913:
855:
1684:
1679:
528:
1587:
195:
The firm was originally founded in 1996 as BioAsia
Investments (due to its former association with Asian investors) by Frank Kung and
791:
395:
1472:
1449:
740:"Amyris Announces Agreements For $ 50 Million in Second Tranche of Equity Financing, Exceeding Previous Target of $ 95 Million"
453:
1920:
1662:
765:
1930:
1900:
420:
222:
companies. Originally it started investing in early stage companies but later on more towards growth stage companies and
1910:
1667:
1352:
1187:
1497:
1492:
1487:
1482:
1477:
1175:
1544:
886:
649:
554:
1754:
1704:
1642:
1602:
1549:
1314:
1258:
977:
848:
262:
1940:
1857:
1852:
1151:
1021:
1161:
1837:
1832:
1787:
1156:
1120:
981:
127:
1539:
1847:
1812:
1709:
1263:
1060:
933:
909:
199:. The two had previously founded Genelabs Technologies, a biopharmaceutical company that was acquired by
1764:
1672:
1288:
946:
918:
899:
309:
273:
266:
176:
97:
57:
1792:
1577:
1454:
1342:
1193:
1105:
941:
923:
841:
1867:
1729:
1637:
1632:
1628:
1582:
1362:
1248:
1075:
1050:
1842:
1802:
1739:
1734:
1572:
1273:
1218:
1130:
529:"Vivo Capital Raises $ 1.3 Billion For Ninth Healthcare Fund | The Healthcare Technology Report"
388:"Taiwan biotech can take off by overcoming challenges, says Frank Kung, founder of Vivo Capital"
218:. Vivo historically has invested 70% of its capital into biotechnology companies and 30% into
1807:
1534:
1529:
1524:
1439:
996:
972:
956:
894:
359:
242:
196:
87:
1647:
1516:
1427:
1165:
1100:
258:
246:
1827:
1749:
1597:
1559:
1434:
1408:
1304:
1208:
1198:
1179:
1146:
1070:
1065:
1001:
986:
238:
215:
116:
47:
351:
1652:
1567:
1444:
1404:
1203:
1183:
951:
904:
227:
219:
211:
207:
120:
1965:
1759:
1744:
1724:
1612:
1373:
1278:
1253:
1243:
1169:
1017:
387:
184:
1872:
1797:
1769:
1714:
1607:
1283:
1238:
1125:
1110:
991:
352:"VC PROFILE: Vivo Capital Takes Advantage of Growth in China's Health-Care Market"
1657:
1115:
1055:
1035:
769:
710:"China's Sinovac, US' Moderna lead the race to develop vaccine against Covid-19"
254:
499:"U.S. equity firm closes yuan-fund eyeing Chinese medical sector - Nikkei Asia"
1822:
1592:
864:
231:
180:
112:
101:
363:
1719:
1268:
881:
281:
250:
588:"Vivo Capital, Bain Back Chinese Biotech Firm in $ 200 Million Fundraising"
680:"Sino Biopharm invests US$ 515 million in Sinovac's Covid-19 vaccine unit"
619:"Vivo Capital Passes Halfway Mark for Fund IX With at Least $ 863 Million"
28:
766:"Angiotech Pharmaceuticals to be acquired by Vivo, ZQ-led group - PE Hub"
285:
650:"China's Sinovac Biotech gets funding for Covid-19 vaccine development"
277:
200:
1422:
289:
223:
792:"Precision BioSciences Closed on a $ 110 Million Series B Financing"
234:
available. However Vivo still invests in companies at all stages.
179:. It is focused on making public and private investments in the
1377:
837:
833:
826:
151:
421:"Vivo Ventures aims for Asia investment with $ 275M fund"
175:("Vivo") is an American investment firm headquartered in
253:. Other notable companies it has invested in include
1778:
1697:
1621:
1558:
1515:
1506:
1463:
1415:
1297:
1231:
1139:
1093:
1084:
1043:
1010:
965:
932:
880:
871:
146:
136:
126:
108:
93:
81:
63:
53:
43:
35:
1982:Financial services companies based in California
1389:
849:
8:
1992:Privately held companies based in California
1891:Private equity and venture capital investors
555:"GlaxoSmithKline buys Genelabs for $ 57 mln"
21:
1333:Alternative investment management companies
1310:Standards Board for Alternative Investments
1997:Venture capital firms of the United States
1926:
1906:
1863:Taxation of private equity and hedge funds
1680:Private investment in public equity (PIPE)
1512:
1396:
1382:
1374:
1358:
1214:Taxation of private equity and hedge funds
1090:
877:
856:
842:
834:
27:
20:
2002:Private equity firms of the United States
1977:Companies based in Palo Alto, California
461:Taiwan Biomedical Innovation Association
301:
1972:American companies established in 1996
914:fixed-income relative-value investing
470:from the original on December 1, 2022
7:
648:Tirumalaraju, Divya (May 25, 2020).
582:
580:
522:
520:
493:
491:
489:
487:
485:
448:
446:
415:
413:
382:
380:
345:
343:
341:
16:American Healthcare investment firm
598:from the original on April 14, 2022
527:Report, H. T. (September 5, 2019).
768:. October 28, 2019. Archived from
505:from the original on June 24, 2022
14:
802:from the original on May 26, 2023
720:from the original on May 26, 2023
690:from the original on May 26, 2023
660:from the original on May 26, 2023
629:from the original on May 26, 2023
565:from the original on May 26, 2023
535:from the original on May 26, 2023
454:"Fireside Chat：Entrepreneuership"
431:from the original on May 26, 2023
398:from the original on May 26, 2023
350:Gormley, Brian (April 27, 2015).
326:from the original on May 26, 2023
230:with human experimental data and
132:US$ 5.4 billion (March 2023)
1946:
1945:
1936:
1935:
1925:
1916:
1915:
1905:
1896:
1895:
1886:
1885:
1357:
1348:
1347:
1338:
1337:
1328:
1327:
1034:
746:(Press release). August 3, 2017
164:Footnotes / references
1987:Hedge fund firms in California
1663:Publicly traded private equity
1:
1931:List of venture capital firms
1911:List of private equity firms
1668:Business Development Company
1188:security characteristic line
714:www.thehindubusinessline.com
1176:Capital asset pricing model
895:Capital structure arbitrage
276:with additional offices in
245:company that developed the
206:Vivo has three strategies,
69:; 28 years ago
2018:
1755:High-net-worth individuals
1545:Leveraged recapitalization
978:Commodity trading advisors
1881:
1643:Limited liability company
1603:Venture capital financing
1550:Dividend recapitalization
1323:
1315:Managed Funds Association
1259:High-net-worth individual
1032:
654:Pharmaceutical Technology
263:Angiotech Pharmaceuticals
162:
26:
1152:Arbitrage pricing theory
684:South China Morning Post
1710:Institutional investors
1264:Institutional investors
1157:Assets under management
982:managed futures account
744:GlobeNewswire News Room
1848:Liquidation preference
1813:Distribution waterfall
1765:Sovereign wealth funds
1289:Sovereign wealth funds
1061:High-frequency trading
910:Fixed income arbitrage
394:. September 10, 2018.
272:Vivo headquartered in
1921:Venture capital firms
1673:Venture capital trust
1131:Structured securities
947:Distressed securities
919:Statistical arbitrage
905:Equity market neutral
900:Convertible arbitrage
463:. November 19, 2022.
274:Palo Alto, California
267:Precision BioSciences
177:Palo Alto, California
58:Investment management
1901:Private equity firms
1629:Private equity firms
1578:Post-money valuation
1455:Equity co-investment
1249:Financial endowments
1194:Fundamental analysis
942:Shareholder activism
924:Volatility arbitrage
686:. December 7, 2020.
594:. December 8, 2021.
561:. October 30, 2008.
1951:Portfolio companies
1868:Undercapitalization
1720:Insurance companies
1638:Limited partnership
1583:Pre-money valuation
1363:List of hedge funds
1353:Hedge fund managers
1269:Insurance companies
1254:Fund of hedge funds
1162:Black–Scholes model
1076:Proprietary trading
1051:Algorithmic trading
1018:Fund of hedge funds
772:on October 28, 2019
356:Wall Street Journal
138:Number of employees
39:BioAsia Investments
23:
1803:Capital commitment
1573:Business incubator
1540:Buy–sell agreement
1219:Technical analysis
1959:
1958:
1808:Capital structure
1693:
1692:
1535:Divisional buyout
1530:Management buyout
1525:Financial sponsor
1371:
1370:
1227:
1226:
1030:
1029:
997:Long/short equity
973:Convergence trade
957:Special situation
617:Kreutzer, Laura.
501:. June 24, 2022.
243:biopharmaceutical
197:Edgar G. Engleman
170:
169:
88:Edgar G. Engleman
22:Vivo Capital, LLC
2009:
1949:
1948:
1939:
1938:
1929:
1928:
1919:
1918:
1909:
1908:
1899:
1898:
1889:
1888:
1750:Commercial banks
1740:Investment banks
1648:Carried interest
1513:
1416:Investment types
1398:
1391:
1384:
1375:
1361:
1360:
1351:
1350:
1341:
1340:
1331:
1330:
1274:Investment banks
1121:Foreign exchange
1091:
1038:
878:
858:
851:
844:
835:
830:
829:
827:Official website
812:
811:
809:
807:
788:
782:
781:
779:
777:
762:
756:
755:
753:
751:
736:
730:
729:
727:
725:
716:. June 1, 2020.
706:
700:
699:
697:
695:
676:
670:
669:
667:
665:
645:
639:
638:
636:
634:
614:
608:
607:
605:
603:
584:
575:
574:
572:
570:
551:
545:
544:
542:
540:
524:
515:
514:
512:
510:
495:
480:
479:
477:
475:
469:
458:
450:
441:
440:
438:
436:
417:
408:
407:
405:
403:
384:
375:
374:
372:
370:
347:
336:
335:
333:
331:
325:
314:
306:
247:COVID-19 vaccine
237:Vivo has funded
158:
155:
153:
77:
75:
70:
31:
24:
2017:
2016:
2012:
2011:
2010:
2008:
2007:
2006:
1962:
1961:
1960:
1955:
1941:Angel investors
1877:
1828:High-yield debt
1781:financial terms
1780:
1774:
1689:
1617:
1598:Startup company
1554:
1508:
1502:
1459:
1411:
1409:venture capital
1402:
1372:
1367:
1319:
1305:Fund governance
1293:
1223:
1147:Absolute return
1135:
1086:
1080:
1071:Program trading
1066:Prime brokerage
1039:
1026:
1006:
1002:Trend following
987:Dedicated short
961:
928:
885:
873:
867:
862:
825:
824:
821:
816:
815:
805:
803:
790:
789:
785:
775:
773:
764:
763:
759:
749:
747:
738:
737:
733:
723:
721:
708:
707:
703:
693:
691:
678:
677:
673:
663:
661:
647:
646:
642:
632:
630:
616:
615:
611:
601:
599:
586:
585:
578:
568:
566:
553:
552:
548:
538:
536:
526:
525:
518:
508:
506:
497:
496:
483:
473:
471:
467:
456:
452:
451:
444:
434:
432:
427:. May 8, 2007.
419:
418:
411:
401:
399:
386:
385:
378:
368:
366:
349:
348:
339:
329:
327:
323:
312:
308:
307:
303:
298:
239:Sinovac Biotech
228:clinical trials
216:Venture capital
193:
166:
150:
142:73 (March 2023)
139:
119:
117:Venture capital
115:
86:
73:
71:
68:
17:
12:
11:
5:
2015:
2013:
2005:
2004:
1999:
1994:
1989:
1984:
1979:
1974:
1964:
1963:
1957:
1956:
1954:
1953:
1943:
1933:
1923:
1913:
1903:
1893:
1882:
1879:
1878:
1876:
1875:
1870:
1865:
1860:
1855:
1850:
1845:
1840:
1835:
1830:
1825:
1820:
1815:
1810:
1805:
1800:
1795:
1790:
1784:
1782:
1776:
1775:
1773:
1772:
1767:
1762:
1760:Family offices
1757:
1752:
1747:
1745:Merchant banks
1742:
1737:
1732:
1727:
1722:
1717:
1712:
1707:
1701:
1699:
1695:
1694:
1691:
1690:
1688:
1687:
1682:
1677:
1676:
1675:
1670:
1660:
1655:
1653:Management fee
1650:
1645:
1640:
1635:
1625:
1623:
1619:
1618:
1616:
1615:
1610:
1605:
1600:
1595:
1590:
1585:
1580:
1575:
1570:
1568:Angel investor
1564:
1562:
1556:
1555:
1553:
1552:
1547:
1542:
1537:
1532:
1527:
1521:
1519:
1510:
1504:
1503:
1501:
1500:
1495:
1490:
1485:
1480:
1475:
1469:
1467:
1461:
1460:
1458:
1457:
1452:
1447:
1442:
1437:
1432:
1431:
1430:
1419:
1417:
1413:
1412:
1405:Private equity
1403:
1401:
1400:
1393:
1386:
1378:
1369:
1368:
1366:
1365:
1355:
1345:
1335:
1324:
1321:
1320:
1318:
1317:
1312:
1307:
1301:
1299:
1295:
1294:
1292:
1291:
1286:
1281:
1279:Merchant banks
1276:
1271:
1266:
1261:
1256:
1251:
1246:
1244:Family offices
1241:
1235:
1233:
1229:
1228:
1225:
1224:
1222:
1221:
1216:
1211:
1206:
1204:Securitization
1201:
1196:
1191:
1173:
1159:
1154:
1149:
1143:
1141:
1137:
1136:
1134:
1133:
1128:
1123:
1118:
1113:
1108:
1103:
1097:
1095:
1088:
1082:
1081:
1079:
1078:
1073:
1068:
1063:
1058:
1053:
1047:
1045:
1041:
1040:
1033:
1031:
1028:
1027:
1025:
1024:
1014:
1012:
1008:
1007:
1005:
1004:
999:
994:
989:
984:
975:
969:
967:
963:
962:
960:
959:
954:
952:Risk arbitrage
949:
944:
938:
936:
930:
929:
927:
926:
921:
916:
907:
902:
897:
891:
889:
887:relative value
875:
869:
868:
863:
861:
860:
853:
846:
838:
832:
831:
820:
819:External links
817:
814:
813:
783:
757:
731:
701:
671:
640:
609:
576:
546:
516:
481:
442:
409:
376:
337:
300:
299:
297:
294:
220:medical device
208:Private equity
192:
189:
168:
167:
160:
159:
148:
144:
143:
140:
137:
134:
133:
130:
124:
123:
121:Private equity
110:
106:
105:
95:
91:
90:
83:
79:
78:
65:
61:
60:
55:
51:
50:
45:
41:
40:
37:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
2014:
2003:
2000:
1998:
1995:
1993:
1990:
1988:
1985:
1983:
1980:
1978:
1975:
1973:
1970:
1969:
1967:
1952:
1944:
1942:
1934:
1932:
1924:
1922:
1914:
1912:
1904:
1902:
1894:
1892:
1884:
1883:
1880:
1874:
1871:
1869:
1866:
1864:
1861:
1859:
1856:
1854:
1851:
1849:
1846:
1844:
1841:
1839:
1836:
1834:
1831:
1829:
1826:
1824:
1821:
1819:
1816:
1814:
1811:
1809:
1806:
1804:
1801:
1799:
1796:
1794:
1791:
1789:
1786:
1785:
1783:
1777:
1771:
1768:
1766:
1763:
1761:
1758:
1756:
1753:
1751:
1748:
1746:
1743:
1741:
1738:
1736:
1733:
1731:
1728:
1726:
1725:Fund of funds
1723:
1721:
1718:
1716:
1715:Pension funds
1713:
1711:
1708:
1706:
1703:
1702:
1700:
1696:
1686:
1683:
1681:
1678:
1674:
1671:
1669:
1666:
1665:
1664:
1661:
1659:
1656:
1654:
1651:
1649:
1646:
1644:
1641:
1639:
1636:
1634:
1630:
1627:
1626:
1624:
1620:
1614:
1613:Venture round
1611:
1609:
1606:
1604:
1601:
1599:
1596:
1594:
1591:
1589:
1586:
1584:
1581:
1579:
1576:
1574:
1571:
1569:
1566:
1565:
1563:
1561:
1557:
1551:
1548:
1546:
1543:
1541:
1538:
1536:
1533:
1531:
1528:
1526:
1523:
1522:
1520:
1518:
1514:
1511:
1505:
1499:
1496:
1494:
1491:
1489:
1486:
1484:
1481:
1479:
1476:
1474:
1473:Early history
1471:
1470:
1468:
1466:
1462:
1456:
1453:
1451:
1448:
1446:
1443:
1441:
1438:
1436:
1433:
1429:
1426:
1425:
1424:
1421:
1420:
1418:
1414:
1410:
1406:
1399:
1394:
1392:
1387:
1385:
1380:
1379:
1376:
1364:
1356:
1354:
1346:
1344:
1336:
1334:
1326:
1325:
1322:
1316:
1313:
1311:
1308:
1306:
1303:
1302:
1300:
1296:
1290:
1287:
1285:
1284:Pension funds
1282:
1280:
1277:
1275:
1272:
1270:
1267:
1265:
1262:
1260:
1257:
1255:
1252:
1250:
1247:
1245:
1242:
1240:
1239:Vulture funds
1237:
1236:
1234:
1230:
1220:
1217:
1215:
1212:
1210:
1207:
1205:
1202:
1200:
1197:
1195:
1192:
1189:
1185:
1181:
1177:
1174:
1171:
1170:delta neutral
1167:
1163:
1160:
1158:
1155:
1153:
1150:
1148:
1145:
1144:
1142:
1138:
1132:
1129:
1127:
1126:Money markets
1124:
1122:
1119:
1117:
1114:
1112:
1109:
1107:
1104:
1102:
1099:
1098:
1096:
1092:
1089:
1083:
1077:
1074:
1072:
1069:
1067:
1064:
1062:
1059:
1057:
1054:
1052:
1049:
1048:
1046:
1042:
1037:
1023:
1022:Multi-manager
1019:
1016:
1015:
1013:
1009:
1003:
1000:
998:
995:
993:
990:
988:
985:
983:
979:
976:
974:
971:
970:
968:
964:
958:
955:
953:
950:
948:
945:
943:
940:
939:
937:
935:
931:
925:
922:
920:
917:
915:
911:
908:
906:
903:
901:
898:
896:
893:
892:
890:
888:
883:
879:
876:
870:
866:
859:
854:
852:
847:
845:
840:
839:
836:
828:
823:
822:
818:
801:
797:
793:
787:
784:
771:
767:
761:
758:
745:
741:
735:
732:
719:
715:
711:
705:
702:
689:
685:
681:
675:
672:
659:
655:
651:
644:
641:
628:
624:
620:
613:
610:
597:
593:
592:Bloomberg.com
589:
583:
581:
577:
564:
560:
556:
550:
547:
534:
530:
523:
521:
517:
504:
500:
494:
492:
490:
488:
486:
482:
466:
462:
455:
449:
447:
443:
430:
426:
422:
416:
414:
410:
397:
393:
389:
383:
381:
377:
365:
361:
357:
353:
346:
344:
342:
338:
322:
318:
311:
305:
302:
295:
293:
291:
287:
283:
279:
275:
270:
268:
264:
260:
256:
252:
248:
244:
240:
235:
233:
229:
225:
221:
217:
213:
212:Public equity
209:
204:
202:
198:
190:
188:
186:
185:biotechnology
182:
178:
174:
165:
161:
157:
149:
145:
141:
135:
131:
129:
125:
122:
118:
114:
111:
107:
103:
99:
96:
92:
89:
84:
80:
66:
62:
59:
56:
52:
49:
46:
42:
38:
34:
30:
25:
19:
1873:Vintage year
1798:Capital call
1770:Crowdfunding
1705:Corporations
1608:Venture debt
1116:Fixed income
992:Global macro
934:Event-driven
804:. Retrieved
795:
786:
774:. Retrieved
770:the original
760:
748:. Retrieved
743:
734:
722:. Retrieved
713:
704:
692:. Retrieved
683:
674:
662:. Retrieved
653:
643:
631:. Retrieved
622:
612:
600:. Retrieved
591:
567:. Retrieved
558:
549:
537:. Retrieved
507:. Retrieved
472:. Retrieved
460:
433:. Retrieved
424:
400:. Retrieved
391:
367:. Retrieved
355:
328:. Retrieved
316:
304:
271:
241:, a Chinese
236:
232:case studies
205:
194:
187:industries.
173:Vivo Capital
172:
171:
163:
154:.vivocapital
94:Headquarters
44:Company type
18:
1735:Foundations
1658:Pledge fund
1450:Secondaries
1343:Hedge funds
1106:Derivatives
1101:Commodities
1056:Day trading
966:Directional
865:Hedge funds
425:VentureBeat
369:January 13,
255:WuXi AppTec
1966:Categories
1823:Envy ratio
1730:Endowments
1593:Seed money
1507:Terms and
1298:Governance
872:Investment
310:"Form ADV"
296:References
191:Background
181:healthcare
113:Hedge fund
102:California
85:Frank Kung
1793:Cap table
1698:Investors
1622:Structure
1440:Mezzanine
1428:Leveraged
1232:Investors
882:Arbitrage
392:DIGITIMES
364:0099-9660
282:Hong Kong
251:CoronaVac
203:in 2008.
98:Palo Alto
1843:Leverage
1779:Related
1509:concepts
874:strategy
800:Archived
796:BioSpace
718:Archived
688:Archived
658:Archived
627:Archived
596:Archived
563:Archived
533:Archived
503:Archived
465:Archived
429:Archived
396:Archived
321:Archived
286:Shanghai
109:Products
82:Founders
54:Industry
36:Formerly
1853:M&A
1560:Venture
1465:History
1435:Venture
1094:Markets
1085:Related
1044:Trading
806:May 26,
776:May 26,
750:May 26,
724:May 26,
694:May 26,
664:May 26,
633:May 26,
602:May 26,
569:May 26,
559:Reuters
539:May 26,
509:May 26,
474:May 26,
435:May 26,
402:May 26,
330:May 26,
278:Beijing
201:GSK plc
147:Website
72: (
64:Founded
48:Private
1818:EBITDA
1517:Buyout
1445:Growth
1423:Buyout
1166:Greeks
1111:Equity
362:
290:Taipei
259:Amyris
224:buyout
104:, U.S.
1633:funds
1498:2020s
1493:2010s
1488:2000s
1483:1990s
1478:1980s
1209:Short
1199:Hedge
1180:alpha
1087:terms
1011:Other
468:(PDF)
457:(PDF)
324:(PDF)
313:(PDF)
1685:SPAC
1631:and
1588:SAFE
1407:and
1184:beta
1140:Misc
808:2023
778:2023
752:2023
726:2023
696:2023
666:2023
635:2023
604:2023
571:2023
541:2023
511:2023
476:2023
437:2023
404:2023
371:2024
360:ISSN
332:2023
288:and
265:and
214:and
183:and
156:.com
74:1996
67:1996
1858:PME
1838:IRR
1833:IPO
1788:AUM
623:WSJ
317:SEC
257:,
152:www
128:AUM
1968::
1186:/
1182:/
1168::
1020:/
980:/
912:/
798:.
794:.
742:.
712:.
682:.
656:.
652:.
625:.
621:.
590:.
579:^
557:.
531:.
519:^
484:^
459:.
445:^
423:.
412:^
390:.
379:^
358:.
354:.
340:^
319:.
315:.
292:.
284:,
280:,
269:.
261:,
249:,
210:,
100:,
1397:e
1390:t
1383:v
1190:)
1178:(
1172:)
1164:(
884:/
857:e
850:t
843:v
810:.
780:.
754:.
728:.
698:.
668:.
637:.
606:.
573:.
543:.
513:.
478:.
439:.
406:.
373:.
334:.
76:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
